• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺素能对红细胞生成的调节:正常人和真性红细胞增多症患者集落形成细胞的体外研究

Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man.

作者信息

Mladenovic J, Adamson J W

出版信息

Br J Haematol. 1984 Feb;56(2):323-32. doi: 10.1111/j.1365-2141.1984.tb03959.x.

DOI:10.1111/j.1365-2141.1984.tb03959.x
PMID:6691924
Abstract

The effect of hormonal interactions on human erythroid colony growth has been studied using the beta adrenergic agonist, isoproterenol. The growth of colonies derived from both erythroid burst-forming cells (BFU-E) and erythroid colony-forming cells (CFU-E) was enhanced in the presence of isoproterenol. While isoproterenol was effective at all concentrations of erythropoietin (Ep) in cultures of marrow cells, an increase in BFU-E-derived colonies in peripheral blood cultures could be detected only at suboptimal levels of Ep concentrations. The isoproterenol effect was blocked by an agent with beta 2 receptor specificity (butoxamine), and L-isomeric configuration (L-propranolol). The stimulatory effect appeared to be mediated by a receptor different from that for Ep or for phytohaemagglutinin-stimulated leucocyte conditioned medium. Circulating BFU-E from eight patients with polycythaemia vera were also studied. Those colonies which grew in the absence of added Ep increased with isoproterenol; in cultures from normal subjects and in patients with secondary erythrocytosis, agonist stimulation was seen only in the presence of Ep. These studies provide evidence that the growth of both normal and neoplastic erythroid progenitors may be modulated by hormonal interactions.

摘要

已使用β肾上腺素能激动剂异丙肾上腺素研究了激素相互作用对人红系集落生长的影响。在异丙肾上腺素存在的情况下,源自红系爆式集落形成细胞(BFU-E)和红系集落形成细胞(CFU-E)的集落生长均得到增强。虽然异丙肾上腺素在骨髓细胞培养物中的所有促红细胞生成素(Ep)浓度下均有效,但仅在Ep浓度处于次优水平时,才能检测到外周血培养物中源自BFU-E的集落增加。异丙肾上腺素的作用可被具有β2受体特异性的药物(布托沙明)和L-异构体构型(L-普萘洛尔)阻断。刺激作用似乎是由一种不同于Ep或植物血凝素刺激的白细胞条件培养基的受体介导的。还研究了8例真性红细胞增多症患者的循环BFU-E。那些在未添加Ep的情况下生长的集落随着异丙肾上腺素而增加;在正常受试者和继发性红细胞增多症患者的培养物中,仅在有Ep存在时才可见激动剂刺激。这些研究提供了证据,表明正常和肿瘤性红系祖细胞的生长可能受到激素相互作用的调节。

相似文献

1
Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man.肾上腺素能对红细胞生成的调节:正常人和真性红细胞增多症患者集落形成细胞的体外研究
Br J Haematol. 1984 Feb;56(2):323-32. doi: 10.1111/j.1365-2141.1984.tb03959.x.
2
An analysis of peripheral blood burst forming units-erythroid in the polycythaemic states.红细胞增多症状态下外周血红细胞爆式集落形成单位的分析
Scand J Haematol. 1983 Oct;31(4):293-7. doi: 10.1111/j.1600-0609.1983.tb00656.x.
3
Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies.真性红细胞增多症和慢性粒细胞白血病中红系祖细胞体外生长的比较:仅真性红细胞增多症有内源性集落。
Leuk Res. 1989;13(4):331-8. doi: 10.1016/0145-2126(89)90070-2.
4
Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow.真性红细胞增多症:人骨髓长期连续培养中的造血研究
J Cell Physiol Suppl. 1982;1:79-85. doi: 10.1002/jcp.1041130413.
5
In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.红系祖细胞的体外培养生长及血清促红细胞生成素测定在真性红细胞增多症鉴别诊断中的应用
Eur J Clin Invest. 1998 Jul;28(7):569-76. doi: 10.1046/j.1365-2362.1998.00331.x.
6
Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny.
Blood. 1983 May;61(5):876-84.
7
Erythroid colony formation in primary proliferative polycythaemia, idiopathic erythrocytosis and secondary polycythaemia: sensitivity to erythropoietic stimulating factors.
Clin Lab Haematol. 1983;5(2):121-9. doi: 10.1111/j.1365-2257.1983.tb01344.x.
8
Characteristics of circulating erythroid colony-forming cells in normal and polycythaemic man.
Br J Haematol. 1982 Jul;51(3):377-84. doi: 10.1111/j.1365-2141.1982.tb02792.x.
9
Erythroid colony growth from peripheral blood and bone marrow in polycythaemia.真性红细胞增多症患者外周血和骨髓中红系集落生长情况
J Clin Pathol. 1990 Nov;43(11):937-41. doi: 10.1136/jcp.43.11.937.
10
Regeneration of erythroid progenitor cells in polycythemic mice treated with cyclophosphamide.用环磷酰胺治疗的真性红细胞增多症小鼠中红系祖细胞的再生
Exp Hematol. 1985 Jan;13(1):67-73.

引用本文的文献

1
The effect of the four pharmacological pillars of heart failure on haemoglobin level.心力衰竭的四大药物治疗支柱对血红蛋白水平的影响。
Ann Med Surg (Lond). 2024 Jan 29;86(3):1575-1583. doi: 10.1097/MS9.0000000000001773. eCollection 2024 Mar.
2
Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives.交感肾上腺素能对造血的调节:现有证据及治疗前景综述
Front Cell Neurosci. 2015 Aug 5;9:302. doi: 10.3389/fncel.2015.00302. eCollection 2015.
3
Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
聚乙二醇化透明质酸酶和多巴胺受体拮抗剂对博来霉素诱导的小鼠肺纤维化的调节作用
PLoS One. 2015 Apr 30;10(4):e0125065. doi: 10.1371/journal.pone.0125065. eCollection 2015.
4
Relation between red cell distribution width and clinical outcome after surgery for congenital heart disease in children.儿童先天性心脏病手术后红细胞分布宽度与临床结局的关系。
Pediatr Cardiol. 2012 Oct;33(7):1021-5. doi: 10.1007/s00246-012-0220-0.
5
Anemia and heart failure: a cause of progression or only a consequence?贫血与心力衰竭:是病情进展的原因还是仅仅是一种后果?
Heart Int. 2007;3(1):1. doi: 10.4081/hi.2007.1. Epub 2007 Jun 15.
6
Anemia in Cardio-Renal Syndrome: clinical impact and pathophysiologic mechanisms.心肾综合征中的贫血:临床影响和病理生理机制。
Heart Fail Rev. 2011 Nov;16(6):603-7. doi: 10.1007/s10741-011-9230-x.
7
Dose-response relationship between norepinephrine and erythropoiesis: evidence for a critical threshold.去甲肾上腺素与红细胞生成之间的量效关系:临界阈值的证据。
J Surg Res. 2010 Oct;163(2):e85-90. doi: 10.1016/j.jss.2010.03.051. Epub 2010 Apr 18.
8
G-protein-coupled receptors in normal human erythroid progenitor cells.正常人红细胞祖细胞中的G蛋白偶联受体。
Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):11-20. doi: 10.1007/BF00168910.